Hancock Whitney’s St Jude Medical STJ Stock Holding History

Hancock Whitney’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-41,031	Closed	-$2.59M	–	593
2015 Q3	$2.59M	Buy	+41,031	New	+$2.93M	0.11%	240
2014 Q4	–	Sell	-227,453	Closed	-$13.7M	–	567
2014 Q3	$13.7M	Buy	227,453 +5,218	+2%	+$341K	0.52%	66
2014 Q2	$15.4M	Buy	222,235 +6,589	+3%	+$427K	0.56%	52
2014 Q1	$14.1M	Buy	215,646 +206,416	+2,236%	+$13.4M	0.55%	58
2013 Q4	$572K	Hold	9,230	–	–	0.02%	325
2013 Q3	$495K	Sell	9,230 -1,900	-17%	-$97.9K	0.02%	347
2013 Q2	$508K	Buy	+11,130	New	+$482K	0.03%	326

Other funds holding STJ

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $677M AUM 27.58% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Hancock Whitney's STJ Position: Q4 2015 in Review

Hancock Whitney sold out of St Jude Medical (STJ) in Q4 2015, closing a stake of 41,031 shares — an estimated $2.59M sold.

Hancock Whitney first reported a position in STJ in Q2 2013 and held it in 7 quarters. The position peaked at $15.4M in Q2 2014. 620 funds tracked by Wall St. Rank hold STJ as of Q4 2015.

Hancock Whitney reported no remaining St Jude Medical position as of Q4 2015 after selling out during the quarter.
Hancock Whitney sold 41,031 St Jude Medical shares in Q4 2015, an estimated $2.59M.
Hancock Whitney first reported a position in St Jude Medical in Q2 2013 and held it in 7 quarters.
Hancock Whitney's St Jude Medical position peaked at $15.4M in Q2 2014.
620 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2015.

Based on Hancock Whitney's 13F filing for Q4 2015, filed 12 Feb 2016.